Top Markets
Coin of the day
PCL, Inc. PCL, Inc.

PCL, Inc.

241820
Rang in Aktien #31786
PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic... PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic (IVD) solutions, encompassing both diagnostic products and specialized platform services. The company's primary offerings include comprehensive multiplex kits designed to detect antibodies to Human Immunodeficiency Virus (HIV) types 1 and 2, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human T-lymphotropic Virus (HTLV) types 1 and 2. These kits also identify specific antigens such as HIV p24, HCV core, and HBV surface markers in human serum or plasma samples. In addition to these, PCL markets Ai, a rapid diagnostic test kit capable of typing influenza A and B strains; Cancer6, a screening kit for multiple tumor biomarkers; and the sciLINER LATERAL FLOW DISPENSER, an advanced dispensing device for membrane materials featuring active visual drop volume control. Beyond its product portfolio, PCL offers valuable platform services. These include a sol-gel spotting service, which immobilizes client-specified materials using the proprietary SolB reagent, and an SG ID service, providing customers with identified molecules of interest securely immobilized within the SolB reagent. PCL, Inc. is headquartered in Seoul, South Korea.
Aktienkurs
$0.21291741
Zuletzt synchronisiert: 2025-04-18
Marktkapitalisierung
$12.07M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
KR
Handel PCL, Inc. (241820)

Kategorie

EPS für PCL, Inc. (241820)
EPS zum September 2025 TTM: $-0.52
Laut den aktuellen Finanzberichten und dem Aktienkurs von PCL, Inc. beträgt das aktuelle EPS des Unternehmens (TTM) $-0.52. Am Ende des Jahres 2023 betrug das EPS $-0.39 eine Steigerung gegenüber dem EPS von 2022, das $-0.09 betrug.
EPS-Verlauf von PCL, Inc. von 2015 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
2026 (TTM) $-0.52 -17.86%
2024 $-0.63 64.08%
2023 $-0.39 329.81%
2022 $-0.09 -88.51%
2021 $-0.78 -240.66%
2020 $0.56 -345.09%
2019 $-0.23 31.54%
2018 $-0.17 39.00%
2017 $-0.12 91.81%
2016 $-0.06 22.31%
2015 $-0.05 0.00%
EPS für ähnliche Unternehmen oder Wettbewerber
Unternehmen EPS EPS-Differenz Land
$3.11 -700.97%
US
$9.73 -1,980.19%
US
$3.59 -793.72%
IE
$2.48 -579.23%
US
$1.74 -436.23%
US